Inscriptions closes depuis le:
28 octobre 2008
|
|
| |
Mardi
11 novembre 2008 |
|
A partir de 16h00 : ouverture du bureau d'accueil |
Session d'ouverture |
17h00-20h00 |
|
17h15 : Welcome address par Prof. Alice Dautry, Directrice générale de l'Institut Pasteur, Paris, France
17h30 : Sir Gustav Nossal, University of Melbourne, Victoria, Australia.
| 18h30-20h00 : Cocktail de bienvenue dans le hall du CIS |
|
| |
|
|
Mercredi
12 novembre 2008 |
|
8h00 : ouverture du bureau d'accueil |
Session 1. Tracking emerging infectious diseases: the way forward
Modérateurs. Arnaud Fontanet et Marc Lipsitch |
9h00-12h30 |
|
9h00 : Robin Weiss, University College of London, GB
Origin of human infections.
9h30 : Antoine Gessain, Institut Pasteur, Paris, France
Emergence of novel human retroviruses in Central Africa by interspecies transmission : Importance of viral surveillance.
10h00 : Marc Lipsitch, Harvard School of Public Health, EU
New diseases: modeling emergence, spread and control.
11h00 : Malik Peiris, Hong Kong University Pasteur Research Center, Hong-Kong
Confronting emerging infectious diseases : lessons from SARS and avian flu.
11h30 : Richard Hatchett, NIH, Bethesda, EU
Planning and decision-making in the face of uncertainty.
12h00 : Robert May, Oxford University, GB
Parasites, people and policies.
|
| |
|
12h30-14h30 : Déjeuner-buffet dans le hall du CIS + Session posters n°1 |
| 14h30-18h00 |
|
Session 2. Understanding Infectious Diseases
Modérateurs. Jim Di Santo et Arturo Zychlinski |
14h30 : Pascale Cossart, Institut Pasteur, Paris, France
Multiple approaches to address infectious processes : the paradigm of Listeria monocytogenes.
15h00 : David Sibley, Washington University, St-Louis, EU
Molecular basis of virulence and innate resistance in toxoplasmosis.
15h30 : Karla Kirkegaard, Stanford University, EU
New lessons from poliovirus: dominant drug targets and novel routes of viral spread.
16h30 : Elena Levashina, Institut de Biologie Moleculaire et Cellulaire, Strasbourg, France
Complement-like antimalarial responses in the mosquito Anopheles gambiae.
17h00 : Arturo Zychlinski, Max-Planck Institute, Berlin, Allemagne
Innate immunity to bacterial infections.
17h30 Philippe Sansonetti, Institut Pasteur, Paris, France
Subverting innate immune defenses: a survival strategy for pathogens. |
| Soirée |
|
19h00 : Départ en bus devant l'Institut Pasteur pour le dîner de gala au Musée Jacquemart-André. |
Jeudi
13 novembre 2008 |
|
8h00 : ouverture du bureau d'accueil |
Session 3. Treating Infectious Diseases
Modérateurs. Jean-Marc Ghigo et Julian Davies |
| 9h00-12h30 |
| 9h00 : Laurent Gutmann, Hôpital Européen Georges-Pompidou, Paris, France
Antibiotic treatments and bacteria: winners and losers.
9h30 : Patrice Courvalin, Institut Pasteur, Paris, France
Evasion of bacteria to antibiotic action.
10h00 : Didier Mazel, Institut Pasteur, Paris, France
Understanding the dynamics of antibiotic resistance cassettes in integrons.
11h00 : David Roos, University of Pennsylvania, Philadelphia, EU
Pathogen bioinformatics: prioritizing targets for drugs, vaccines & diagnostics.
11h30 : Françoise Barré-Sinoussi, Institut Pasteur, Paris, France - Prix Nobel de Médecine 2008
Lessons from HIV/AIDS: from pathogenesis to future challenges in prevention and therapy.
12h00 : Julian Davies, University of British Columbia, Vancouver, Canada
The end of antibiotics?
|
|
|
12h30-15h00 : Déjeuner-buffet dans le hall du CIS + Session posters n°2 |
| 15h00-19h00 |
|
Session 4. Preventing Infectious Diseases
Modérateurs. Geneviève Milon et Gustav Nossal |
| |
15h00 : Ralph Steinman, The Rockefeller University, New-York, EU
Dendritic cells: a vehicle for vaccine development.
15h30 : Philippe Bousso, Institut Pasteur, Paris, France
Visualizing the cellular orchestration of innate and adaptive immune responses in vivo.
16h00 : Victor Nussenzweig, New York University School of Medicine, New-York, EU
Rationale for a malaria vaccine.
17h00 : John Clemens, International Vaccine Institute, Séoul, Corée du Sud
Herd protection by bacterial enteric vaccines: a new dimension.
17h30 : Claude Leclerc, Institut Pasteur, Paris, France
New vaccines based on the targeting of innate, adaptive and regulatory immune responses.
18h00 : Rino Rappuoli, Novartis Vaccines, Sienne, Italie
Vaccines: a health insurance of the 21st century. |
|
Session de clôture |
|
18h30 : Ogobara Doumbo, Université de Bamako, Mali |
|
|
Dernière mise à jour :
7/11/08 16:09
|
|
